180 Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
2,712
+206
+8% +$18.1K 0.02% 428
2026
Q1
$227K Buy
+2,506
New +$230K 0.03% 423
2021
Q4
Sell
-1,748
Closed -$248K 411
2021
Q3
$248K Sell
1,748
-14
-0.8% -$2.06K 0.05% 318
2021
Q2
$249K Sell
1,762
-35
-2% -$5.67K 0.06% 310
2021
Q1
$292K Hold
1,797
0.07% 256
2020
Q4
$279K Buy
1,797
+5
+0.3% +$706 0.08% 242
2020
Q3
$247K Sell
1,792
-138
-7% -$18K 0.09% 213
2020
Q2
$253K Buy
+1,930
New +$222K 0.1% 202

Other funds holding ZBH

180 Wealth Advisors's ZBH Position: Q2 2026 in Review

180 Wealth Advisors increased its Zimmer Biomet (ZBH) stake by 8.2% in Q2 2026, buying an estimated $18.1K and bringing the position to 2,712 shares worth $234K. The position accounts for 0.02% of the portfolio, ranked #428.

180 Wealth Advisors first reported a position in ZBH in Q2 2020 and has held it in 8 quarters since. The position peaked at $292K in Q1 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • 180 Wealth Advisors held 2,712 shares of Zimmer Biomet worth $234K as of Q2 2026.
  • 180 Wealth Advisors bought 206 Zimmer Biomet shares in Q2 2026, an estimated $18.1K.
  • Zimmer Biomet made up 0.02% of 180 Wealth Advisors's portfolio in Q2 2026, its #428 holding.
  • 180 Wealth Advisors first reported a position in Zimmer Biomet in Q2 2020 and has held it in 8 quarters since.
  • 180 Wealth Advisors's Zimmer Biomet position peaked at $292K in Q1 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.